Innoviva is fueling healthcare innovation by investing in areas of high unmet medical need as well as developing and commercializing differentiated therapies.
We are a diversified holding company anchored by a robust royalty business with a leading critical care and infectious disease platform and a growing portfolio of healthcare assets.
Strongly cashflow-positive, durable core royalty business stemming from widely used respiratory products
Commercial stage, growth-oriented critical care and infectious disease platform supported by late-stage pipeline
Valuable diversified asset portfolio offers optionality, downside protection, and long-term value creation
Thoughtful, robust approach to capital deployment with long-term horizon
Strong track record and value creation focus
© 2025 Innoviva. All rights reserved. Terms & Conditions | Privacy Policy | Contact
Sitemap | Terms & Conditions | Privacy Policy | Contact
© 2022 Innoviva. All rights reserved.